EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY: (Tables)

6 Months Ended

Sep. 30, 2013

EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:

Schedule of reconciliation of the numerator and denominator of basic and diluted earnings per share

A reconciliation of the numerator and denominator of basic and diluted earnings per share is shown below (in thousands, except per share amounts):

	For the quarter ended September 30					For the six months ended September 30
	2013		2012			2013			2012
Basic earnings per share:
Net earnings	$	9,864	$	16,372		$	22,959		$	29,571
Net gain (loss) attributable to noncontrolling interest	25		(139		)	(60		)	(273		)
Net earnings attributable to Acxiom	$	9,839	$	16,511		$	23,019		$	29,844
Basic weighted-average shares outstanding	73,778		75,009			73,728			75,741
Basic earnings per share:
Net earnings	$	0.13	$	0.22		$	0.31		$	0.39
Net loss attributable to noncontrolling interest	—		—			—			—
Net earnings attributable to Acxiom	$	0.13	$	0.22		$	0.31		$	0.39
Diluted earnings per share:
Basic weighted-average shares outstanding	73,778		75,009			73,728			75,741
Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method	2,258		2,016			2,036			1,800
Diluted weighted-average shares outstanding	76,036		77,025			75,764			77,541
Diluted earnings per share:
Net earnings	$	0.13	$	0.21		$	0.30		$	0.38
Net loss attributable to noncontrolling interest	—		—			—			—
Net earnings attributable to Acxiom	$	0.13	$	0.21		$	0.30		$	0.38

Schedule of antidilutive options, warrants and restricted stock units excluded from computation of earnings per share

As of September 30, 2013, the Company had options and warrants outstanding providing for the purchase of approximately 8.5 million shares of common stock together with restricted stock units relating to 2.2 million shares of stock.  Options, warrants and restricted stock units that were outstanding during the periods presented, but were not included in the computation of diluted earnings per share because the effect was antidilutive are shown below (in thousands, except per share amounts):

	For the quarter ended September 30				For the six months ended September 30
	2013		2012		2013		2012
Number of shares outstanding under options, warrants and restricted stock units	2,224		4,762		3,390		7,093
Range of exercise prices for options and warrants	$	21.46-$62.06	$	17.76-$62.06	$	21.46-$62.06	$	15.31-$62.06

Schedule of accumulated balances for each component of other comprehensive income

The accumulated balances for each component of other comprehensive income are as follows (dollars in thousands):

	September 30, 2013			March 31, 2013
Foreign currency translation	$	13,088		$	12,175
Unrealized loss on interest rate swap	(334		)	(752		)
	$	12,754		$	11,423